DrugPatentWatch Database Preview

Deflazacort - Generic Drug Details

« Back to Dashboard

What are the generic sources for deflazacort and what is the scope of deflazacort patent protection?

Deflazacort is the generic ingredient in one branded drug marketed by Ptc Therap and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for deflazacort. Two suppliers are listed for this compound.

Summary for deflazacort

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	2
Drug Master File Entries:	3
Suppliers / Packagers:	2
Bulk Api Vendors:	47
Clinical Trials:	14
Patent Applications:	4,408
DailyMed Link:	deflazacort at DailyMed

Pharmacology for deflazacort

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Synonyms for deflazacort

(11beta,16beta)-21-(Acetyloxy)-11-hydroxy-2'-methyl-5'H-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione

(11beta,16beta)-21-(acetyloxy)-11-hydroxy-2'-methyl-5'H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione

11b,21-Dihydroxy-2'-methyl-5'bH-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione 21-acetate

11beta,21-Dihydroxy-2'-methyl-5'betaH-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione 21-acetate

11beta,21-dihydroxy-2'-methyl-5'betaH-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione 2'-acetate

14484-47-0

2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a,10-trimethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d]oxazol-8b-yl)-2-oxoethyl acetate

2-[(1S,2S,4R,8S,9S,11S,12S,13R)-11-HYDROXY-6,9,13-TRIMETHYL-16-OXO-5-OXA-7-AZAPENTACYCLO[10.8.0.0(2),?.0?,?.0(1)(3),(1)?]ICOSA-6,14,17-TRIEN-8-YL]-2-OXOETHYL ACETATE

2-[(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]oxazol-6b-yl]-2-oxoethyl acetate

4'H-Pregna-1,4-dieno(16,17-d)oxazole-3,20-dione, 21-(acetyloxy)-11-hydroxy-2'-methyl-, (11beta,16beta)-

484D470

5'-beta-H-Pregna-1,4-dieno(17,16-d)oxazole-3,20-dione, 11-beta,21-dihydroxy-2'-methyl-, 21-acetate

5'H-Pregna-1,4-dieno(17,16-d)oxazole-3,20-dione, 21-(acetyloxy)-11-hydroxy-2'-methyl-, (11beta,16beta)-

AB01274724_02

AB01274724-01

AB2000350

AC1L4PC6

ACN-043364

AK322033

AKOS015895199

Azacort

azacortinol

C-22370

C25H31NO6

Calcort

CAS-14484-47-0

CC-26308

CCG-220817

CHEBI:135720

CHEMBL1201891

Cortax

Cortax;Decortil;Deflanil;Calcort

CS-2349

D03671

D4523

DB11921

Decortil

Deflan

Deflanil

Deflazacort (Calcort)

Deflazacort (USAN/INN)

Deflazacort [USAN:INN:BAN]

Deflazacort, >=98% (HPLC)

Deflazacort, United States Pharmacopeia (USP) Reference Standard

Deflazacortum

Deflazacortum [INN-Latin]

Dezacor

dezacort

DL-458-IT

DL-458IT

DR002729

DSSTox_CID_378

DSSTox_GSID_20378

DSSTox_RID_75552

DTXSID9020378

EINECS 238-483-7

Emflaza

Enzocort

Flantadin

GTPL9477

H894

HY-13609

KR5YZ6AE4B

KS-1158

L-5458

Lantadin

MDL 458

MDL-458

MFCD00866106

MolPort-003-846-170

NCGC00255189-01

NCGC00263521-01

Oxazacort

PL046242

Pregna-1,4-diene-11,21-diol(17alpha,16alpha-d)2'-methyloxazoline-3,20-dione-21-acetate

pregna-1,4-diene-11beta,21-diol-3,20-dione[17alpha,16alpha-d]-2'-methyloxazoline 21-acetate

Q-101371

RL01810

s1888

SCHEMBL4018

ST51052738

Tox21_112506

Tox21_112506_1

Tox21_301415

UNII-KR5YZ6AE4B

Zamene

ZINC4212809

US Patents and Regulatory Information for deflazacort

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ptc Therap	EMFLAZA	deflazacort	TABLET;ORAL	208684-004	Feb 9, 2017		RX	Yes	Yes
Ptc Therap	EMFLAZA	deflazacort	TABLET;ORAL	208684-002	Feb 9, 2017		RX	Yes	No
Ptc Therap	EMFLAZA	deflazacort	SUSPENSION;ORAL	208685-001	Feb 9, 2017		RX	Yes	Yes
Ptc Therap	EMFLAZA	deflazacort	TABLET;ORAL	208684-004	Feb 9, 2017		RX	Yes	Yes
Ptc Therap	EMFLAZA	deflazacort	TABLET;ORAL	208684-001	Feb 9, 2017		RX	Yes	No
Ptc Therap	EMFLAZA	deflazacort	TABLET;ORAL	208684-001	Feb 9, 2017		RX	Yes	No